144 related articles for article (PubMed ID: 24314585)
1. Inflammatory myopathy with abundant macrophages (IMAM): the immunology revisited.
Rinnenthal JL; Goebel HH; Preuße C; Lebenheim L; Schumann M; Moos V; Schneider T; Heppner FL; Stenzel W
Neuromuscul Disord; 2014 Feb; 24(2):151-5. PubMed ID: 24314585
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory myopathy with abundant macrophages and dermatomyositis: two stages of one disorder or two distinct entities?
Brunn A; Hans VJ; Vogelgesang S; Deckert M
Acta Neuropathol; 2009 Dec; 118(6):793-801. PubMed ID: 19590880
[TBL] [Abstract][Full Text] [Related]
3. Th2-M2 immunity in lesions of muscular sarcoidosis and macrophagic myofasciitis.
Preusse C; Goebel HH; Pehl D; Rinnenthal JL; Kley RA; Allenbach Y; Heppner FL; Vorgerd M; Authier FJ; Gherardi R; Stenzel W
Neuropathol Appl Neurobiol; 2015 Dec; 41(7):952-63. PubMed ID: 25711697
[TBL] [Abstract][Full Text] [Related]
4. Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile.
Preuße C; Goebel HH; Held J; Wengert O; Scheibe F; Irlbacher K; Koch A; Heppner FL; Stenzel W
Am J Pathol; 2012 Dec; 181(6):2161-71. PubMed ID: 23058368
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory myopathy with abundant macrophages (IMAM): a condition sharing similarities with cytophagic histiocytic panniculitis and distinct from macrophagic myofasciitis.
Bassez G; Authier FJ; Lechapt-Zalcman E; Delfau-Larue MH; Plonquet A; Coquet M; Illa I; Gherardi RK
J Neuropathol Exp Neurol; 2003 May; 62(5):464-74. PubMed ID: 12769186
[TBL] [Abstract][Full Text] [Related]
6. Dermatomyositis, lobar panniculitis and inflammatory myopathy with abundant macrophages.
Carrera E; Lobrinus JA; Spertini O; Gherardi RK; Kuntzer T
Neuromuscul Disord; 2006 Jul; 16(7):468-71. PubMed ID: 16809038
[TBL] [Abstract][Full Text] [Related]
7. TRPM7 modulates macrophage polarization by STAT1/STAT6 pathways in RAW264.7 cells.
Li L; Wei C; Cai S; Fang L
Biochem Biophys Res Commun; 2020 Dec; 533(4):692-697. PubMed ID: 33153718
[TBL] [Abstract][Full Text] [Related]
8. Focal myositis: a clinicopathologic study of 115 cases of an intramuscular mass-like reactive process.
Auerbach A; Fanburg-Smith JC; Wang G; Rushing EJ
Am J Surg Pathol; 2009 Jul; 33(7):1016-24. PubMed ID: 19363438
[TBL] [Abstract][Full Text] [Related]
9. Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin.
Jaguin M; Houlbert N; Fardel O; Lecureur V
Cell Immunol; 2013 Jan; 281(1):51-61. PubMed ID: 23454681
[TBL] [Abstract][Full Text] [Related]
10. Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9.
Lv R; Bao Q; Li Y
Mol Med Rep; 2017 Dec; 16(6):9111-9119. PubMed ID: 28990062
[TBL] [Abstract][Full Text] [Related]
11. Signal transducer and activator of transcription 1 in human muscle: implications in inflammatory myopathies.
Illa I; Gallardo E; Gimeno R; Serrano C; Ferrer I; Juárez C
Am J Pathol; 1997 Jul; 151(1):81-8. PubMed ID: 9212734
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target.
Crescioli C; Sottili M; Bonini P; Cosmi L; Chiarugi P; Romagnani P; Vannelli GB; Colletti M; Isidori AM; Serio M; Lenzi A; Di Luigi L
Eur J Cell Biol; 2012 Feb; 91(2):139-49. PubMed ID: 22176919
[TBL] [Abstract][Full Text] [Related]
13. The immune system in sporadic inclusion body myositis patients is not compromised by blood-flow restricted exercise training.
Jensen KY; Jacobsen M; Schrøder HD; Aagaard P; Nielsen JL; Jørgensen AN; Boyle E; Bech RD; Rosmark S; Diederichsen LP; Frandsen U
Arthritis Res Ther; 2019 Dec; 21(1):293. PubMed ID: 31852482
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic uncertainty in the inflammatory myopathies.
Verity MA
Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):1051-70. PubMed ID: 18068861
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
[TBL] [Abstract][Full Text] [Related]
16. Modulation of chitotriosidase during macrophage differentiation.
Di Rosa M; Malaguarnera G; De Gregorio C; D'Amico F; Mazzarino MC; Malaguarnera L
Cell Biochem Biophys; 2013 Jun; 66(2):239-47. PubMed ID: 23152091
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies.
De Bleecker JL; Meire VI; Declercq W; Van Aken EH
Neuromuscul Disord; 1999 Jun; 9(4):239-46. PubMed ID: 10399751
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle pathology in 2 siblings infected with Toxoplasma gondii.
Calore EE; Minkovski R; Khoury Z; Seguro AC; Perez Calore NM; Cavaliere MJ
J Rheumatol; 2000 Jun; 27(6):1556-9. PubMed ID: 10852291
[TBL] [Abstract][Full Text] [Related]
19. Pro-inflammatory cytokines negatively regulate PPARγ mediated gene expression in both human and murine macrophages via multiple mechanisms.
Nagy ZS; Czimmerer Z; Szanto A; Nagy L
Immunobiology; 2013 Nov; 218(11):1336-44. PubMed ID: 23870825
[TBL] [Abstract][Full Text] [Related]
20. Beta-chemokine receptor expression in idiopathic inflammatory myopathies.
De Paepe B; De Bleecker JL
Muscle Nerve; 2005 May; 31(5):621-7. PubMed ID: 15772970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
